Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125517662 | 12551766 | 2 | F | 20160628 | 20160713 | 20160713 | EXP | IT-CIPLA LTD.-2014IT00547 | CIPLA | CUOMO I, KOTZALIDIS GD, CACCIA F, DANESE E, MANFREDI G, GIRARDI P. CITALOPRAM ASSOCIATED GAMBLING A CASE REPORT. J GAMBL STUD.. 2014;2:467 TO 473 | 0.00 | Y | 0.00000 | 20160713 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125517662 | 12551766 | 1 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Intravenous (not otherwise specified) | UNK | Y | U | 0 | ||||||||
| 125517662 | 12551766 | 2 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Intravenous (not otherwise specified) | 40 MG/DAY | Y | U | 0 | 40 | MG | ||||||
| 125517662 | 12551766 | 3 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 40 MG, QD | Y | U | 0 | 40 | MG | ||||||
| 125517662 | 12551766 | 4 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MG, QD | Y | U | 0 | 20 | MG | ||||||
| 125517662 | 12551766 | 5 | PS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | 5 MG, QD | U | U | 203333 | 5 | MG | ||||||
| 125517662 | 12551766 | 6 | SS | OLANZAPINE. | OLANZAPINE | 1 | U | U | 203333 | ||||||||||
| 125517662 | 12551766 | 7 | SS | ALPRAZOLAM. | ALPRAZOLAM | 1 | Unknown | 0.5 MG, BID | 0 | .5 | MG | ||||||||
| 125517662 | 12551766 | 8 | SS | ALPRAZOLAM. | ALPRAZOLAM | 1 | Unknown | 1.5 MG, QD | 0 | 1.5 | MG | ||||||||
| 125517662 | 12551766 | 9 | SS | PREGABALIN. | PREGABALIN | 1 | Unknown | 225 MG, QD | U | U | 0 | 225 | MG | ||||||
| 125517662 | 12551766 | 10 | SS | PAROXETINE. | PAROXETINE | 1 | Oral | 20 MG, QD | U | U | 0 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125517662 | 12551766 | 1 | Major depression |
| 125517662 | 12551766 | 5 | Somatic symptom disorder |
| 125517662 | 12551766 | 6 | Major depression |
| 125517662 | 12551766 | 10 | Depressed mood |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125517662 | 12551766 | OT |
| 125517662 | 12551766 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125517662 | 12551766 | Autoimmune thyroiditis | |
| 125517662 | 12551766 | Condition aggravated | |
| 125517662 | 12551766 | Drug ineffective | |
| 125517662 | 12551766 | Fracture | |
| 125517662 | 12551766 | Gambling disorder | |
| 125517662 | 12551766 | Illness anxiety disorder | |
| 125517662 | 12551766 | Irritability | |
| 125517662 | 12551766 | Logorrhoea | |
| 125517662 | 12551766 | Mania | |
| 125517662 | 12551766 | Road traffic accident | |
| 125517662 | 12551766 | Sleep disorder | |
| 125517662 | 12551766 | Stress |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125517662 | 12551766 | 10 | 2006 | 2008 | 0 |